Cargando…
Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients
BACKGROUND: End-stage renal disease yields susceptibility to both ischemia and bleeding. The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is not established in dialysis patients, who are usually excluded from randomized studies. Since recent studie...
Autores principales: | Park, Seokwoo, Kim, Yaerim, Jo, Hyung Ah, Lee, Soojin, Kim, Mi-Sook, Yang, Bo Ram, Lee, Joongyub, Han, Seung Seok, Lee, Hajeong, Lee, Jung Pyo, Joo, Kwon Wook, Lim, Chun Soo, Kim, Yon Su, Kim, Dong Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577762/ https://www.ncbi.nlm.nih.gov/pubmed/33125004 http://dx.doi.org/10.1093/ckj/sfaa037 |
Ejemplares similares
-
Incremental Peritoneal Dialysis May be Beneficial for Preserving Residual Renal Function Compared to Full-dose Peritoneal Dialysis
por: Lee, Yeonhee, et al.
Publicado: (2019) -
Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group
por: Park, Sehoon, et al.
Publicado: (2019) -
Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent
por: Yoon, Yong-Hoon, et al.
Publicado: (2022) -
Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
por: Cho, Yun-Kyeong, et al.
Publicado: (2014) -
Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
por: Kim, Sunwon, et al.
Publicado: (2023)